Concepedia

Martin van Eickels

MV

63

Publications

8.5K

Citations

36

H-Index

1997

Active since

Affiliations

Bayer (Germany)(Current)

University of Birmingham

St George's, University of London

McMaster University

Harvard University

Martin van Eickels is an author at Bayer (Germany) specializing in medicine, cardiovascular disease, and cardiology.

Top concepts

Publications per year

1997–2023

63

Publications

63

Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI

C. Michael Gibson, Roxana Mehran, Christoph Bode et al. · New England Journal of Medicine · 2016 · 1.5K citations · Full text

Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation

Stefan H. Hohnloser, Harry J.G.M. Crijns, Martin van Eickels et al. · New England Journal of Medicine · 2009 · 1.1K citations · Full text

Estrogen Receptor α Rapidly Activates the IGF-1 Receptor Pathway

Stefan Kahlert, Simone Nuedling, Martin van Eickels et al. · Journal of Biological Chemistry · 2000 · 467 citations · Full text

XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation

A. John Camm, Pierre Amarenco, Sylvia Haas et al. · European Heart Journal · 2015 · 447 citations · Full text

Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry

Ajay K. Kakkar, Iris Mueller, Jean‐Pierre Bassand et al. · PLoS ONE · 2013 · 440 citations · Full text

Rows per page

1–5 of 63